Results 141 to 150 of about 10,317 (226)

The Role of Thymoma and Thymic Hyperplasia as Prognostic Risk Factors for Secondary Generalisation in Adults with Ocular Myasthenia Gravis: A Systematic Narrative Review. [PDF]

Br Ir Orthopt J, 2023
Wilson L, Davis H.
europepmc   +1 more source

Cavernous Sinus Dural Arteriovenous Fistula Initially Misdiagnosed As Ocular Myasthenia Gravis: A Case Report. [PDF]

Cureus
Yamamoto S, Watanabe G, Akao G, Sato K, Suzuki Y.   +4 more
europepmc   +1 more source

Ocular myasthenia gravis saccades as a measure of extraocular muscle function. [PDF]

Front Ophthalmol (Lausanne), 2022
Wong SH, Bancroft MJ, Tailor VK, Abbas M, Sekar A, Noble C, Theodorou M, Kaski D.   +7 more
europepmc   +1 more source

Thymectomy in Ocular Myasthenia Gravis: Results Before and After Generalization and Prognostic Predictors of Outcomes. [PDF]

J Clin Med
Nachira D, Congedo MT, Kuzmych K, Evoli A, Iorio R, Vita ML, Petracca-Ciavarella L, Nocera A, Sassorossi C, Evangelista J, Lyberis P, Comacchio GM, Brandolini J, Aprile V, Zifara CC, Mastromarino MG, Patirelis A, Asteggiano E, Anile M, Venuta F, Imperatori A, Ambrogi V, Solli P, Dell'Amore A, Lucchi M, Melfi F, Ibrahim M, Ruffini E, Rea F, Margaritora S, Meacci E.   +30 more
europepmc   +1 more source

Commentary: Ocular myasthenia gravis: Interpreting the investigations. [PDF]

Indian J Ophthalmol, 2022
Nair AG.
europepmc   +1 more source

Low-dose rituximab in AChR antibody-positive ocular myasthenia gravis: Efficacy and safety-A preliminary study. [PDF]

Medicine (Baltimore)
Mao B, Wang R, Liu X, Ping D, Xu Y, Ning L.   +5 more
europepmc   +1 more source

Successful Surgical Repair of Ventricular Septal Defect in a Child With Ocular Myasthenia Gravis and History of Myeloid Sarcoma Post-HSCT: A Multidisciplinary Approach. [PDF]

Clin Case Rep
Rong S, Xu W, Li X.
europepmc   +1 more source

Avelumab-Induced Ocular Myasthenia Gravis: A Case Report. [PDF]

Cureus
Khaokong R, Ling YT, Mugunthan T.
europepmc   +1 more source

Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis. [PDF]

Neurotherapeutics, 2023
Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, Ozawa Y, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S, Nagane Y, Utsugisawa K.   +19 more
europepmc   +1 more source

The Spurious Palsy-Fluctuation of Ocular Myasthenia Gravis Symptoms Characterized by Orthoptics. [PDF]

J Neuroophthalmol
Grimm SL, Fierz FC, Bockisch CJ, Weber KP.   +3 more
europepmc   +1 more source